A study of HIV RNA viral load in AIDS patients with bacterial pneumonia

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue 1, 1996, Pages 23-26

  Bush, Charlene E ^a,b   Donovan, Richard M ^a   Markowitz, Norman P ^a   Kvale, Paul ^b   Saravolatz, Louis D ^a  

^a Henry Ford Health System Division of Infectious Diseases   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Bacterial pneumonia; Plasma HIV RNA; Surrogate markers; Viral load

Indexed keywords

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; VIRUS CELL INTERACTION;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029759972     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199609000-00004     Document Type: Article

References (13)

1. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
2. O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-I RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996;334:426-31.
3. Vandamme AM, Van Dooren S, Kok W, et al. Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. J Virol Methods 1995;52:121-32.
4. Urdea MS, Wilber JC, Yeghiazarian T, et al. Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. Aids 1993; 7(supp) 2:811-4.
5. Dewar RL, Highbarger HC, Sarmiento MD, et al. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis 1994;170:1172-9.
6. Donovan RM, Bush CE, Markowitz NP, Baxa D, Saravolatz LD. Changes in Human Immunodeficiency Virus (HIV) viral load markers during AIDS-associated opportunistic diseases. J Infect Dis 1996 (in press).
7. Kovacs JA, Baseler M, Dewar RL, et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 patients with human immunodeficiency virus infection: a preliminary study. N Engl J Med 1995;332:567-75.
8. Staprans SI, Hamilton BL, Follansbee SE, et al. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995;182:1727-37.
9. O'Brien WA, Grovit-Ferbas K, Namazi A, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995;86:1082-9.
10. Stanley SK, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;334:1222-30.
11. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus: pulmonary complications of HIV Infection Study Group. N Engl J Med 1995;333:845-51.
12. Chan IS, Neaton JD, Saravolatz LD, Crane LR, Osterberger J. Frequencies of opportunistic diseases prior to death among HIV-infected persons: Community Programs for Clinical Research on AIDS. AIDS 1995;9:1145-51.
13. Wallace JM, Rao AV, Glassroth J, et al. Respiratory illness in persons with human immunodeficiency virus infection: the pulmonary complications of HIV Infection Study Group. Am Rev Respir Dis 1993;148:1523-9.